Beta Drugs Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was INR 1,123.9 million compared to INR 880.96 million a year ago. Revenue was INR 1,127.17 million compared to INR 885.5 million a year ago.

Net income was INR 158.35 million compared to INR 117.51 million a year ago. Basic earnings per share from continuing operations was INR 16.47 compared to INR 12.22 a year ago. Diluted earnings per share from continuing operations was INR 16.47 compared to INR 12.22 a year ago.